Compliance

Keith Korenchuk counsels and advises global companies on regulatory and compliance matters worldwide, with a focus on compliance program effectiveness, compliance program implementation, operations and evaluation, and related regulatory counseling and advice.  He works in a wide variety of industries and sectors including consumer products, electronics, energy, financial services, life sciences, medical device, pharmaceutical, and technology.

Mr. Korenchuk provides regulatory and compliance guidance, advice, and solutions regarding:

• US and global compliance systems design, implementation, and ongoing assessment
• Compliance program evaluation under the US Sentencing Guidelines, the UK Bribery Act adequate procedures guidance, the OECD Guidelines on Internal Controls, and related national and international compliance standards
• Specific compliance program activities including codes of conduct, training program design and delivery, monitoring, and corrective action responses
• Global anti-bribery legislation, including the US Foreign Corrupt Practices Act, the UK Bribery Act, the Organization for Economic Co-operation and Development (OECD) Anti-bribery Convention, and related national implementing legislation
• Internal financial controls design, implementation and remediation to institute effective oversight of key risk areas
• Internal and government initiated investigations
• Enterprise-wide risk management systems and programs
• Global, regional, and country specific codes of practice and conduct, including industry codes of conduct issued by industry associations

His work spans many business functions, including research and development, global marketing, sales and marketing, strategic alliances/acquisitions, government affairs, and procurement.

Since 2001, Mr. Korenchuk has been included in The Best Lawyers in America. He has developed, led, and implemented "hands-on" educational and healthcare programs that provide pharmaceuticals and healthcare services, teachers, school supplies, library resources, and computers to indigenous communities in South America for the past 12 years.

Prior Business Experience

Mr. Korenchuk's prior experience includes serving as the CEO of a company that focused on pharmaceutical and healthcare sector compliance, as well as the CEO of a research and development company that focused on homeland security technologies.

Compliance Representative Matters

• Assisting a global company in implementing a revised worldwide compliance program, including program design and structure, code of conduct/policy revision, training, monitoring, auditing, investigations processes, as well as implementation assessment.
• Evaluating regulatory issues and compliance effectiveness in discrete programs and activities, including key risk areas and activities based upon a company-focused risk assessment.
• Assisting a variety of companies to evaluate and enhance their worldwide due diligence and ongoing compliance oversight of third party agents and distributors.
• Assisting companies in conducting overall compliance program evaluations for subsidiaries/functions in Europe, the Middle East, Africa, Latin America, and Asia, and assisting in remediation efforts.
• Providing assistance to the finance function of a global company to evaluate existing internal controls, and assisting in the remediation design and implementation of revised controls.
• Advising the Board of Directors of a global company on compliance program effectiveness and related governance issues.
• Conducting worldwide compliance training for the legal department of a NYSE listed company
• Conceptualizing, designing and implementing anti-corruption training for the top 1500 executives of a NYSE listed company using case studies, interactive discussion and small group settings on country specific and functional bases
• Providing assistance in the conduct of a global multi-jurisdictional investigation under the FCPA
• Providing assistance in negotiation of Corporate Integrity Agreements (CIAs) with the Office of the Inspector General (OIG) of the US Department of Health and Human Services, as well as ongoing support of CIA implementation, ongoing operation, and related OIG site visits.
• Evaluating the sales and marketing function of a newly acquired business unit for a company and providing post-closing remediation recommendations and assistance.